Who Prioritizes Innovation? R&D Spending Compared for Infosys Limited and Manhattan Associates, Inc.

R&D Spending: Infosys vs. Manhattan Associates

__timestampInfosys LimitedManhattan Associates, Inc.
Wednesday, January 1, 201411000000048953000
Thursday, January 1, 201510875072253859000
Friday, January 1, 201611766096954736000
Sunday, January 1, 201711603006857704000
Monday, January 1, 201810994715471896000
Tuesday, January 1, 201911691537487608000
Wednesday, January 1, 202012729840284276000
Friday, January 1, 20217099754497628000
Saturday, January 1, 2022129656701111877000
Sunday, January 1, 2023135037609126814000
Monday, January 1, 2024137689000
Loading chart...

Unlocking the unknown

Innovation in Focus: A Comparative Analysis of R&D Spending

In the ever-evolving landscape of technology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Infosys Limited and Manhattan Associates, Inc. have demonstrated varying levels of investment in R&D, reflecting their strategic priorities.

From 2014 to 2023, Infosys consistently allocated a significant portion of its resources to R&D, with expenditures peaking in 2023 at approximately 135 million USD. This represents a 23% increase from its 2014 spending. Meanwhile, Manhattan Associates, Inc. has shown a remarkable upward trend, with R&D spending surging by 181% over the same period, reaching nearly 127 million USD in 2023.

This data highlights a strategic shift in Manhattan Associates, Inc., as it intensifies its focus on innovation, closing the gap with Infosys. The absence of data for Infosys in 2024 suggests a potential shift or reevaluation in their R&D strategy.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
28 Jan 2025